Bimatoprost Is Currently Approved For The Listing Of Two Brands

Bimatoprost is currently approved for the listing of two brands, namely Lumigan and Latisse. Lumigan is considered to be the strongest local anti-glaucoma drugs, which was approved by the FDA in 2001 for local ophthalmic preparations. Latisse is the only FDA-approved eyelash hyperplasia in the world. Clinical trials have shown that it can make eyelashes longer and more dense, but the prescription drugs.

the answer is negative. Although the final results have not yet been published, it is foreseeable that the probability of complete eradication of male hormones is significantly lower than that of pro-prostaglandin. One thing is certain: the future bimatoprost will be Minor’s strongest opponent, excluding the price and cost of treatment factors, or may completely replace Minor.

As early as 2012, the researchers found that the treatment of glaucoma drugs than the horse prostaglandin is to help hair loss grow new hair, and through the experiment once again verified the use of bimatoprost. Although the eyelash lengthening fluid, but also with the propagidin such substances, but the growth of eyelashes and hair growth mechanism is completely different, so the researchers do not determine whether the prostaglandin can also be treated hair loss, after a preliminary study, the answer Has been affirmed.

Leave a Reply

Your email address will not be published. Required fields are marked *